1. Supplements for Smoking-Related Lung Diseases
- Author
-
Naser A. Alsharairi
- Subjects
medicine.medical_specialty ,Lung ,business.industry ,Dietary supplement ,Cancer ,medicine.disease ,respiratory tract diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Health claims on food labels ,030220 oncology & carcinogenesis ,medicine ,In patient ,030212 general & internal medicine ,Intensive care medicine ,Lung cancer ,business ,Asthma - Abstract
Supplements for smoking-related lung diseases are considered as nonfood products and thought to improve health. Multivitamins and antioxidants are the most commonly dietary supplements used by cancer and asthma patients. There are currently no clear regulatory guidelines that include dietary supplements and their effect on lung cancer and asthma patients, particularly in smokers. Several countries have taken steps to overcome challenges in regulating dietary supplements in the marketplace. These challenges include inadequate assurance of safety/efficacy, inaccuracy of product labeling, misleading health claims, and lack of analytical techniques for dietary supplements. There is a need to establish standards and regulation of dietary supplement use in patients with lung cancer and asthma. The aim of this entry is to expand knowledge on dietary supplements use and smoking-related lung diseases (lung cancer and asthma).
- Published
- 2021